Coronavirus COVID-19 Guidance and Information for Healthcare Professionals
Updated January 2023

Healthcare Guidance

Guidance, reporting, patient handouts and more from MSDH

• All MSDH guidance and resources
• Health facilities
• Reporting COVID-19 cases
• Specimen collection, reporting and delivery
• Surveillance
• Vaccination providers
• CDC guidance documents

MS-HAN Messages

Advisories and information related to COVID-19 from the Mississippi Health Alert Network

• Recent and past messages

Therapeutics

• Paxlovid ordering, reporting and resources
• COVID-19 Therapeutics Decision Aid
• Outpatient Administration Guide for Healthcare Providers (HHS.gov) Federal Response to COVID-19: Therapeutics Clinical Implementation Guide
• All therapeutics resources

Healthcare Provider Guidance and Resources

• CDC Infection Control Recommendations for Healthcare Professionals During COVID-19
• NIH Clinical Guidelines: Therapies for High-Risk, Nonhospitalized Patients
• NIH Panel's Statement on Prioritizing the Use of Outpatient Therapies
• CDC Guidance for Healthcare Personnel with Potential COVID-19 Exposure
• Handout: What to Do After You Have Been Tested for COVID-19
• Handout: Home Isolation for Individuals with COVID-19
• CDC guidance related to COVID-19

• Mississippi Health Alert Network messages related to COVID-19

Patient Handouts

• Home Isolation for Individuals with COVID-19

• Molnupiravir fact sheet FDA
• Paxlovid fact sheet FDA

Vaccination Providers

• Enrollment and Resources for COVID-19 Vaccination Providers

Reporting COVID-19 Cases

• Updated SARS-CoV-2 Reporting RequirementsMarch 31, 2022
• Electronic Reporting of COVID-19 Test Results to MSDHOptions and data formats
• Request NBS Account for COVID-19 ReportingChoose this option if you run non-rapid, non-point-of-care COVID-19 tests (typically hospitals, reference labs, large clinic systems, etc.)
• Sign up for Simple Report for COVID-19 ReportingThis reporting tool only works with rapid and point-of-care COVID-19 tests (typically clinics, schools, and non-traditional testing sites). These facilities can view and edit data entered.

COVID-19 Deaths

• Death Reporting Q & A for Medical Examiners, Coroners and Physicians
• CDC Guidance on Certifying COVID-19 Deaths PDF
• How to get a Mississippi death certificate PDF

COVID-19 Therapeutics

• Therapeutics locator
• Billing for COVID-19 therapeutics
• Monoclonal antibody therapy
• Evusheld
• Oral antivirals
• Remdesivir

• Contact information for Mississippi COVID-19 therapeutics providers PDF
• Overview of Therapeutics for the Prevention or Treatment of COVID-19 (HHS.gov) PDF

Monoclonal Antibody Therapy

There are no monoclonal antibodies currently authorized in the U.S. for the outpatient treatment of COVID-19.

The following monoclonal antibody products are no longer authorized for use in the U.S.:

• Bamlanivimab
• Bamlanivimab/Etesevimab
• Bebtelovimab
• REGEN-COV
• Sotrovimab

Evusheld

As of January 26, 2023, Evusheld is no longer authorized for Emergency use for pre-exposure prophylaxis (prevention) of COVID-19.

Oral Antivirals

Ordering: The federal government has designed the Healthcare Provider Order Portal (HPOP) for management of COVID-19 therapeutics. Please place your order in HPOP. You will be able to see courses ordered for your site on your HPOP account. If you do not have an HPOP account, please contact C19Therapeutics@msdh.ms.gov

Required reporting: Courses administered and courses available of Paxlovid and molnupiravir should be entered into HPOP by the provider site at the end of every business day. Timely and accurate inventory reporting is necessary for federal partners to determine subsequent state allocations

Resources:

• PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers (FDA)
• Paxlovid Resources from Pfizer.com
• Paxlovid fact sheet for healthcare providers (FDA)
• Paxlovid fact sheet for patients/caregivers (FDA)
• Molnupiravir resources from Merck.com
• Molnupiravir fact sheet for healthcare providers (FDA)
• Molnupiravir fact sheet for patients/caregivers (FDA)

Find pharmacies that prescribe and dispense oral antivirals

• List of Mississippi pharmacies that dispense oral antivirals (PDF)

Therapeutics Locator

Use this interactive map to locate a facility that has one of the authorized therapeutics for COVID-19.

• View this locator full-screen

Presentation: Oral Antiviral Therapeutics

Overview and details of use, safety, interactions, target population and more (July 19, 2022)

• View this video full screen
• Slides of this video PDF
• Online resources mentioned in this video
• COVID-19 Therapeutics Decision Aid (hhs.gov)

Remdesivir

Remdesivir has been studied in non-hospitalized patients with mild to moderate COVID-19 who are at high risk of progressing to severe disease and is approved by the FDA for use in both hospitalized and non-hospitalized patients.

• NIH Treatment Guidelines

Ordering: Remdesivir is commercially available and should be ordered through standard pharmaceutical procurement processes.

Billing for COVID-19 Therapeutics

• CMS Billing

Health Facilities

• Long-term care facility guidance documents
• Mississippi COVID-19 System of Care

Specimen Collection, Delivery and Reporting

• COVID-19 Specimen Collection
• COVID-19 Lab Requisition Form
• COVID-19 Refrigerated Specimen Packaging
• COVID-19 Frozen Specimen Packaging
• COVID-19 Specimen Transport and Delivery

Specimen Reporting

• COVID-19 Specimen Reporting
• MPHL Fax Reporting Agreement

SARS-CoV-2 Virus Strain Surveillance

• COVID-19 Enhanced Surveillance Submission Recommendations
• SARS-CoV-2 Enhanced Surveillance Submission Requisition Form 1198

Map and Directions for Laboratory Dropoff

The Dr. F.E.”ED” Thompson, Jr. Public Health Laboratory Facility is on the State Department of Health's central office campus in Jackson, MS at 350 East Woodrow Wilson Drive, Jackson, 39216.

Local Delivery of Samples: Drop samples off at the rear of the Thompson lab building. Detailed instructions are in our sample shipping guidance.

Dropoff hours: Monday through Friday from 8:00–4:30.

CDC Guidance

Healthcare and EMS

• Home Care Guidance
• Discontinuation of Home Isolation for Persons with COVID-19
• Healthcare Infection Control Guidance
• Clinical Care Guidance
• Healthcare Personnel with Potential COVID-19 Exposure Guidance
• Inpatient Obstetric Healthcare Guidance
• Guidance for EMS

Contact Tracing

• Contact Tracing Information and Guidance
• Collection and Submission of Postmortem Specimens from Deceased Persons with Confirmed or Suspected COVID-19

More from the CDC

• All CDC guidance for healthcare professionals

Links referenced on this page
Recent and past messages		http://msdh.ms.gov/msdhsite/index.cfm/14,21697,420,694,html ok
COVID-19 Therapeutics Decision Aid		https://aspr.hhs.gov/COVID-19/Therapeutics/Documents/COVID-Therapeutics-Decision-Aid.pdf
Outpatient Administration Guide for Healthcare Providers		https://www.phe.gov/emergency/events/COVID19/investigation-MCM/Documents/USG-COVID19-Tx-Playbook.pdf
CDC Infection Control Recommendations for Healthcare Professionals During COVID-19		https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html
NIH Clinical Guidelines: Therapies for High-Risk, Nonhospitalized Patients		https://www.covid19treatmentguidelines.nih.gov/therapies/statement-on-therapies-for-high-risk-nonhospitalized-patients/
NIH Panel's Statement on Prioritizing the Use of Outpatient Therapies		https://www.covid19treatmentguidelines.nih.gov/therapies/statement-on-patient-prioritization-for-outpatient-therapies/
CDC Guidance for Healthcare Personnel with Potential COVID-19 Exposure		https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html
Handout: What to Do After You Have Been Tested for COVID-19		http://msdh.ms.gov/msdhsite/index.cfm/14,19334,420,pdf/HCP_C19_After_Your_Test.pdf
Handout: Home Isolation for Individuals with COVID-19		http://msdh.ms.gov/msdhsite/index.cfm/14,9915,420,pdf/HCP_C19_self_isolate.pdf
Mississippi Health Alert Network messages related to COVID-19		http://msdh.ms.gov/msdhsite/index.cfm/14,21697,420,694,html ok
Home Isolation for Individuals with COVID-19		http://msdh.ms.gov/msdhsite/index.cfm/14,9915,420,pdf/HCP_C19_self_isolate.pdf
Molnupiravir fact sheet		https://www.fda.gov/media/155055/download
Paxlovid fact sheet		https://www.fda.gov/media/155051/download
Enrollment and Resources for COVID-19 Vaccination Providers		http://msdh.ms.gov/msdhsite/index.cfm/14,0,71,975,html ok
Updated SARS-CoV-2 Reporting Requirements		http://msdh.ms.gov/page/resources/18641.pdf
Electronic Reporting of COVID-19 Test Results to MSDH		http://msdh.ms.gov/msdhsite/index.cfm/14,11590,420,pdf/Reporting_COVID-19_Test_Results.pdf
Request NBS Account for COVID-19 Reporting		http://msdh.ms.gov/msdhsite/index.cfm/14,15382,194,html ok
Sign up for		https://simplereport.gov/sign-up/
Death Reporting Q & A for Medical Examiners, Coroners and Physicians		http://msdh.ms.gov/msdhsite/index.cfm/14,22075,420,694,html ok
CDC Guidance on Certifying COVID-19 Deaths		https://www.cdc.gov/nchs/data/nvss/vsrg/vsrg03-508.pdf
How to get a Mississippi death certificate		http://msdh.ms.gov/msdhsite/index.cfm/31,0,109,809,html ok
Contact information for Mississippi COVID-19 therapeutics providers		http://msdh.ms.gov/page/resources/17902.pdf
Overview of Therapeutics for the Prevention or Treatment of COVID-19		https://aspr.hhs.gov/COVID-19/Therapeutics/Documents/side-by-side-overview.pdf
Healthcare Provider Order Portal		https://vpop.cdc.gov/provider/signin/
C19Therapeutics@msdh.ms.gov		mailto:C19Therapeutics@msdh.ms.gov
PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers		https://www.fda.gov/media/158165/download
Paxlovid Resources from Pfizer.com		https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate
Paxlovid fact sheet for healthcare providers		https://www.fda.gov/media/155050/download
Paxlovid fact sheet for patients/caregivers		https://www.fda.gov/media/155051/download
Molnupiravir resources from Merck.com		https://www.merck.com/news/merck-and-ridgebacks-molnupiravir-receives-u-s-fda-emergency-use-authorization-for-the-treatment-of-high-risk-adults-with-mild-to-moderate-covid-19/
Molnupiravir fact sheet for healthcare providers		https://www.fda.gov/media/155054/download
Molnupiravir fact sheet for patients/caregivers		https://www.fda.gov/media/155055/download
List of Mississippi pharmacies that dispense oral antivirals (PDF)		http://msdh.ms.gov/msdhsite/index.cfm/14,17718,420,pdf/AntiviralPharmacies.pdf
View this locator full-screen		https://app.powerbigov.us/view?r=eyJrIjoiMzkxZDYzNmUtYTg3Ni00YzljLWFmODctMDg1Njc5MzE2MjU1IiwidCI6IjU1OTA0MmRjLThiZjAtNGQ4Ni05ZmMwLWZiZjRjNzUwM2M3OSJ9
View this video full screen		https://youtu.be/MJymZ4G-Q8c
Slides of this video		https://msdh.ms.gov/msdhsite/files/Oral_Antivirals_for_COVID-19.pdf
Online resources mentioned in this video		https://msdh.ms.gov/msdhsite/files/Oral_antivirals_resources_July.pdf
COVID-19 Therapeutics Decision Aid (hhs.gov)		https://aspr.hhs.gov/COVID-19/Therapeutics/Documents/COVID-Therapeutics-Decision-Aid.pdf
NIH Treatment Guidelines		https://www.covid19treatmentguidelines.nih.gov/therapies/statement-on-therapies-for-high-risk-nonhospitalized-patients/
CMS Billing		https://www.cms.gov/covid-19-vaccines-and-monoclonal-antibodies
Long-term care facility guidance documents		http://msdh.ms.gov/msdhsite/index.cfm/14,21866,420.html ok
Mississippi COVID-19 System of Care		http://msdh.ms.gov/msdhsite/index.cfm/44,0,397,881,html ok
COVID-19 Specimen Collection		http://msdh.ms.gov/msdhsite/index.cfm/14,8501,420,pdf/COVID-19_Specimen_Collection.pdf
COVID-19 Lab Requisition Form		http://msdh.ms.gov/msdhsite/index.cfm/14,8500,420,pdf/COVID-19_Laboratory_Requisition.pdf
COVID-19 Refrigerated Specimen Packaging		http://msdh.ms.gov/msdhsite/index.cfm/14,8499,420,pdf/COVID-19_Refrigerated_Specimen_Packaging.pdf
COVID-19 Frozen Specimen Packaging		http://msdh.ms.gov/msdhsite/index.cfm/14,8498,420,pdf/COVID-19_Frozen_Specimen_Packaging.pdf
COVID-19 Specimen Transport and Delivery		http://msdh.ms.gov/msdhsite/index.cfm/14,8497,420,pdf/COVID-19_Specimen_Transport.pdf
COVID-19 Specimen Reporting		http://msdh.ms.gov/msdhsite/index.cfm/14,8496,420,pdf/COVID-19_Specimen_Reporting.pdf
MPHL Fax Reporting Agreement		http://msdh.ms.gov/msdhsite/index.cfm/14,8495,420,pdf/MPHL_Fax_Reporting_Agreement.pdf
COVID-19 Enhanced Surveillance Submission Recommendations		http://msdh.ms.gov/msdhsite/index.cfm/14,13625,420,pdf/MSDH_COVID-19_Surveillance.pdf
SARS-CoV-2 Enhanced Surveillance Submission Requisition		http://msdh.ms.gov/page/resources/14128.pdf
Home Care Guidance		https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-home-care.html
Discontinuation of Home Isolation for Persons with COVID-19		https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html
Healthcare Infection Control Guidance		https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control.html
Clinical Care Guidance		https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
Healthcare Personnel with Potential COVID-19 Exposure Guidance		https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html
Inpatient Obstetric Healthcare Guidance		https://www.cdc.gov/coronavirus/2019-ncov/hcp/inpatient-obstetric-healthcare-guidance.html
Guidance for EMS		https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-for-ems.html
Contact Tracing Information and Guidance		https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/index.html
Collection and Submission of Postmortem Specimens from Deceased Persons with Confirmed or Suspected COVID-19		https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-postmortem-specimens.html

Resources referenced
Handout: What to Do After You Have Been Tested for COVID-19		https://msdh.ms.gov/msdhsite/index.cfm/14,19334,420,pdf/HCP_C19_After_Your_Test.pdf ok
Handout: Home Isolation for Individuals with COVID-19		https://msdh.ms.gov/msdhsite/index.cfm/14,9915,420,pdf/HCP_C19_self_isolate.pdf ok
Home Isolation for Individuals with COVID-19		https://msdh.ms.gov/msdhsite/index.cfm/14,9915,420,pdf/HCP_C19_self_isolate.pdf ok
Updated SARS-CoV-2 Reporting Requirements		https://msdh.ms.gov/page/resources/18641.pdf ok
Electronic Reporting of COVID-19 Test Results to MSDH		https://msdh.ms.gov/msdhsite/index.cfm/14,11590,420,pdf/Reporting_COVID-19_Test_Results.pdf ok
Contact information for Mississippi COVID-19 therapeutics providers		https://msdh.ms.gov/page/resources/17902.pdf ok
List of Mississippi pharmacies that dispense oral antivirals (PDF)		https://msdh.ms.gov/msdhsite/index.cfm/14,17718,420,pdf/AntiviralPharmacies.pdf ok
Slides of this video		https://msdh.ms.gov/msdhsite/files/Oral_Antivirals_for_COVID-19.pdf static file not found (check this link)
Online resources mentioned in this video		https://msdh.ms.gov/msdhsite/files/Oral_antivirals_resources_July.pdf static file not found (check this link)
COVID-19 Specimen Collection		https://msdh.ms.gov/msdhsite/index.cfm/14,8501,420,pdf/COVID-19_Specimen_Collection.pdf ok
COVID-19 Lab Requisition Form		https://msdh.ms.gov/msdhsite/index.cfm/14,8500,420,pdf/COVID-19_Laboratory_Requisition.pdf ok
COVID-19 Refrigerated Specimen Packaging		https://msdh.ms.gov/msdhsite/index.cfm/14,8499,420,pdf/COVID-19_Refrigerated_Specimen_Packaging.pdf ok
COVID-19 Frozen Specimen Packaging		https://msdh.ms.gov/msdhsite/index.cfm/14,8498,420,pdf/COVID-19_Frozen_Specimen_Packaging.pdf ok
COVID-19 Specimen Transport and Delivery		https://msdh.ms.gov/msdhsite/index.cfm/14,8497,420,pdf/COVID-19_Specimen_Transport.pdf ok
COVID-19 Specimen Reporting		https://msdh.ms.gov/msdhsite/index.cfm/14,8496,420,pdf/COVID-19_Specimen_Reporting.pdf ok
MPHL Fax Reporting Agreement		https://msdh.ms.gov/msdhsite/index.cfm/14,8495,420,pdf/MPHL_Fax_Reporting_Agreement.pdf ok
COVID-19 Enhanced Surveillance Submission Recommendations		https://msdh.ms.gov/msdhsite/index.cfm/14,13625,420,pdf/MSDH_COVID-19_Surveillance.pdf ok
SARS-CoV-2 Enhanced Surveillance Submission Requisition		https://msdh.ms.gov/page/resources/14128.pdf ok

Find this page at http://msdh.ms.gov/msdhsite/index.cfm/index.cfm

print  close